Navigation Links
1983 Mass Shooting is Hauntingly Familiar
Date:10/31/2013

were unbalanced before going on their rampages, but little was done to intervene.”

Since its release, the Kindle version of “A Voice out of Nowhere” has been an Amazon best-seller in the category of schizophrenia. “It’s not an academic text by any means,” Booth says, “but readers will come away with a new-found appreciation for mental illness and for those who become victims of it. Unfortunately, it isn’t just lack of treatment we need to worry about,” she says, “Inadequate treatment is just as worrisome. If a person is under psychiatric care, is being medicated, and is still capable of mass murder, then we have more of a problem than we are willing to admit.”

BIO: Janice Holly Booth was born and raised in British Columbia. Her first book, Only Pack What You Can Carry, was published by National Geographic in 2011. She has a master’s degree in Leadership and was a non-profit CEO for more than 20 years before becoming a full-time writer and speaker. She currently lives near Charlotte, North Carolina.

Read the full story at http://www.prweb.com/releases/2013/10/prweb11267951.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related medicine news :

1. Have You Seen the Ring Donates Profits to Honor Aurora Shooting Anniversary
2. After the shooting, political violence lives on in kids behavior problems
3. Hartford consensus aims to improve survival after mass shootings
4. News Coverage of Shootings May Boost Stigma of Mental Illness
5. Media coverage of mass shootings contributes to negative attitudes towards mental illness
6. Connective Parenting asks: When It Comes to Mass Shootings—What About Parenting?
7. Broader background checks and denial criteria could help prevent mass shooting catastrophes
8. Parents Key to Easing Psychological Impact of Conn. Shootings
9. UC Davis study finds stray-bullet shootings frequently harm women and children
10. Industry Professionals Attend Familiarisation Trip for Thailand’s Medical and Wellness Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... 2015 LunaDress, with its top dressmaking technologies, ... Now, the business is showing its latest designs of wedding ... According to the company’s CEO, all the fresh new products ... big discounts, up to 80% off. All the clothes from ...
(Date:1/22/2015)... VogueQueen is a seasoned and trusted leader who consistently delivers ... to have it lead the wedding dress industry into the ... dresses for the global market. , “The CEO of VogueQueen ... focuses on continuing the goal of operational excellence and giving ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 The federal court ... the U.S. District Court, Southern District of West Virginia has ... in that proceeding’s first bellwether trial. In an Order dated ... new trial after finding that C.R. Bard had not proven ...
(Date:1/22/2015)... For over 20 years, Dr. David Cruz of ... area has treated just about every type of injury that can ... for those same twenty-plus years, the team at Doctors on ... the best possible doctor. With the combined breadth of ...
(Date:1/22/2015)... Weddingshe.com has added many trendy Champagne wedding dresses ... in the past three years. Today, the business announces a ... to the sales manager of the company, this is on ... This point can be reflected on the discounted wedding dresses ...
Breaking Medicine News(10 mins):Health News:LunaDress Shows The Latest Styles Of Wedding Dresses In 2015 2Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2
... Milan, Altarum Institute VP and Chairman of the Black ... Speaker at Mexico City Business Council on AIDS, ... of,Altarum Institute and a prominent leader and advocate on ... on AIDS conference,Thursday, August 7th in Mexico City. The ...
... the wrong strains during flu season, the FDA should ... other changes to the vaccine composition, according to a ... of the Institute for Operations Research and the Management ... Influenza Vaccine Composition" is by Laura J. Kornish of ...
... Patient Safety Technology, HONOLULU, Aug. 5 ... Queen,s Medical Center will equip 100 additional ... Vigilance Systems,(LifeBed), bringing the total number LifeBed,s ... transforms any bed into a LifeBed, which,invisibly ...
... ... - Adjusted Diluted EPS(1) ... Full-Year 2008 Earnings Estimate - - Conference Call Scheduled ... WST ) today announced results for the second quarter,of 2008. Reported diluted earnings per share of $0.82 ...
... MONTREAL, Aug. 5 /PRNewswire-FirstCall/ - CryoCath(R) Technologies,Inc., the ... announced financial results for the third quarter, ended,June 30, ... Highlights: - Grew revenue in Q3 2008 ... comparable electrophysiology (EP) revenue in Q3 ...
... Backlog Reaches $72 ... Million ... Recently-introduced Odyssey System Building Strong Market Momentum, ST. LOUIS, Aug. 5 ... 2008. Revenue for the recent second quarter increased 36% to $10.7,million compared with ...
Cached Medicine News:Health News:New decision model seeks to avert flu vaccine mismatch of 2007-2008 season 2Health News:Hoana Medical Expands Partnership With The Queen's Medical Center to Improve Patient Safety 2Health News:Hoana Medical Expands Partnership With The Queen's Medical Center to Improve Patient Safety 3Health News:West Announces Second Quarter 2008 Results 2Health News:West Announces Second Quarter 2008 Results 3Health News:West Announces Second Quarter 2008 Results 4Health News:West Announces Second Quarter 2008 Results 5Health News:West Announces Second Quarter 2008 Results 6Health News:West Announces Second Quarter 2008 Results 7Health News:West Announces Second Quarter 2008 Results 8Health News:West Announces Second Quarter 2008 Results 9Health News:West Announces Second Quarter 2008 Results 10Health News:West Announces Second Quarter 2008 Results 11Health News:West Announces Second Quarter 2008 Results 12Health News:West Announces Second Quarter 2008 Results 13Health News:West Announces Second Quarter 2008 Results 14Health News:West Announces Second Quarter 2008 Results 15Health News:West Announces Second Quarter 2008 Results 16Health News:West Announces Second Quarter 2008 Results 17Health News:West Announces Second Quarter 2008 Results 18Health News:West Announces Second Quarter 2008 Results 19Health News:CryoCath Announces Fiscal 2008 Third Quarter Results 2Health News:CryoCath Announces Fiscal 2008 Third Quarter Results 3Health News:CryoCath Announces Fiscal 2008 Third Quarter Results 4Health News:CryoCath Announces Fiscal 2008 Third Quarter Results 5Health News:CryoCath Announces Fiscal 2008 Third Quarter Results 6Health News:CryoCath Announces Fiscal 2008 Third Quarter Results 7Health News:CryoCath Announces Fiscal 2008 Third Quarter Results 8Health News:CryoCath Announces Fiscal 2008 Third Quarter Results 9Health News:CryoCath Announces Fiscal 2008 Third Quarter Results 10Health News:CryoCath Announces Fiscal 2008 Third Quarter Results 11Health News:CryoCath Announces Fiscal 2008 Third Quarter Results 12Health News:CryoCath Announces Fiscal 2008 Third Quarter Results 13Health News:Stereotaxis Reports Record Second Quarter Revenue 2Health News:Stereotaxis Reports Record Second Quarter Revenue 3
(Date:1/23/2015)... 2015 Gem Pharmaceuticals announced today that the initial ... the Company,s Phase 2 clinical trial.  This open-label study ... compound, GPX-150 (an investigational medication), in approximately 30 adults ... Logo - http://photos.prnewswire.com/prnh/20150123/170966LOGO ...
(Date:1/22/2015)... Jan. 22, 2015  Uroplasty, Inc. (NASDAQ: UPI ), ... innovative proprietary products to treat voiding dysfunctions, today reported ... 31, 2014.  Global revenue for the Company,s ... million, a new quarterly revenue record, as compared to ...
(Date:1/22/2015)... SAN DIEGO , Jan. 22, 2015  Profil Institute ... focused on diabetes and obesity, announced today a new ... Drug Development,  published by Springer, a leading global scientific ... extensively analyze and illustrate techniques for use in early ...
Breaking Medicine Technology:Gem Pharmaceuticals Announces Enrollment of Initial Patients in its Phase 2 Clinical Trial to Assess the Efficacy and Safety of GPX-150 in Sarcoma Patients 2Uroplasty Reports Record Revenue in Fiscal Third Quarter 2Uroplasty Reports Record Revenue in Fiscal Third Quarter 3Uroplasty Reports Record Revenue in Fiscal Third Quarter 4Uroplasty Reports Record Revenue in Fiscal Third Quarter 5Uroplasty Reports Record Revenue in Fiscal Third Quarter 6Uroplasty Reports Record Revenue in Fiscal Third Quarter 7Uroplasty Reports Record Revenue in Fiscal Third Quarter 8Uroplasty Reports Record Revenue in Fiscal Third Quarter 9Uroplasty Reports Record Revenue in Fiscal Third Quarter 10Uroplasty Reports Record Revenue in Fiscal Third Quarter 11Uroplasty Reports Record Revenue in Fiscal Third Quarter 12Uroplasty Reports Record Revenue in Fiscal Third Quarter 13Uroplasty Reports Record Revenue in Fiscal Third Quarter 14Uroplasty Reports Record Revenue in Fiscal Third Quarter 15Uroplasty Reports Record Revenue in Fiscal Third Quarter 16Uroplasty Reports Record Revenue in Fiscal Third Quarter 17Uroplasty Reports Record Revenue in Fiscal Third Quarter 18New Textbook "Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development" Provides Critical Review Of Current And Emerging Clinical Investigation Methods 2New Textbook "Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development" Provides Critical Review Of Current And Emerging Clinical Investigation Methods 3
... PARSIPPANY, N.J., July 7, 2011 Watson Pharmaceuticals, Inc. ... United States Court of Appeals for the Federal Circuit ... Southern District of Florida,s February 2011 decision that Watson,s ... Mucinex(R) DM (Dextromethorphan HBr/ Guaifenesin) Extended-Release products do not ...
... 2011 Watson Pharmaceuticals, Inc. (NYSE: ... Laboratories, Inc., filed an Abbreviated New Drug Application ... (FDA) seeking approval to market lisdexamfetamine dimesylate capsules. ... of Shire LLC,s Vyvanse®. Vyvanse® is a prescription ...
Cached Medicine Technology:Watson Confirms Favorable Appeals Court Decision in Mucinex(R) Patent Suit 2Watson Confirms Vyvanse® Patent Challenge 2
... 14A and 14C have been approved. The three ... the variations in the size of the individual ... are designed to stabilize the capsule and have ... of U.S. ophthalmologists. For implatations of the ...
... is a device designed for permanent implantation ... removal surgery. It provides secondary capsular bag ... The CTR is a uniplanar, 270-degree, semi-circle ... absorbing polymethylmethacrylate (PMMA) with one manipulation eyelet ...
Stainless steel cartilage scissors....
Hannum rongeur/grasper with teth in jaws and non-locking design....
Medicine Products: